PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli

被引:166
作者
Li, Yongfang [1 ]
Zhang, Ying [1 ]
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
关键词
D O I
10.1128/AAC.00052-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
When a bactericidal antibiotic is added to a growing bacterial culture, the great majority of the bacterial population is killed but a small number of metabolically quiescent bacteria called persisters survive antibiotic treatment. The mechanism of this bacterial persistence is poorly understood. In Escherichia coh, we identified a new persistence gene, phoU, whose inactivation leads to a generalized higher susceptibility than that of the parent strain to a diverse range of antibiotics, including ampicillin, norfloxacin, and gentamicin, and stresses, such as starvation, acid pH, heat, peroxide, weak acids, and energy inhibitors, especially in stationary phase. The PhoU mutant phenotype could be complemented by a functional phoU gene. Mutation in PhoU leads to a metabolically hyperactive status of the cell, as shown by an increased expression of energy production genes, flagella, and chemotaxis genes and a defect in persister formation. PhoU, whose expression is regulated by environmental changes like nutrient availability and age of culture, is a global negative regulator beyond its role in phosphate metabolism and facilitates persister formation by the suppression of many important cellular metabolic processes. A new model of persister formation based on PhoU as a persister switch is proposed. PhoU may be an ideal drug target for designing new drugs that kill persister bacteria for more effective control of bacterial infections.
引用
收藏
页码:2092 / 2099
页数:8
相关论文
共 29 条
  • [1] [Anonymous], 1996, E COLI SALMONELLA CE
  • [2] Bacterial persistence as a phenotypic switch
    Balaban, NQ
    Merrin, J
    Chait, R
    Kowalik, L
    Leibler, S
    [J]. SCIENCE, 2004, 305 (5690) : 1622 - 1625
  • [3] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
  • [4] Bigger JW, 1944, LANCET, V2, P497
  • [5] AUTOREGULATION OF HIP, AN OPERON THAT AFFECTS LETHALITY DUE TO INHIBITION OF PEPTIDOGLYCAN OR DNA-SYNTHESIS
    BLACK, DS
    IRWIN, B
    MOYED, HS
    [J]. JOURNAL OF BACTERIOLOGY, 1994, 176 (13) : 4081 - 4091
  • [6] Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
    Cole, ST
    Brosch, R
    Parkhill, J
    Garnier, T
    Churcher, C
    Harris, D
    Gordon, SV
    Eiglmeier, K
    Gas, S
    Barry, CE
    Tekaia, F
    Badcock, K
    Basham, D
    Brown, D
    Chillingworth, T
    Connor, R
    Davies, R
    Devlin, K
    Feltwell, T
    Gentles, S
    Hamlin, N
    Holroyd, S
    Hornby, T
    Jagels, K
    Krogh, A
    McLean, J
    Moule, S
    Murphy, L
    Oliver, K
    Osborne, J
    Quail, MA
    Rajandream, MA
    Rogers, J
    Rutter, S
    Seeger, K
    Skelton, J
    Squares, R
    Squares, S
    Sulston, JE
    Taylor, K
    Whitehead, S
    Barrell, BG
    [J]. NATURE, 1998, 393 (6685) : 537 - +
  • [7] Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli
    Correia, Frederick F.
    D'Onofrio, Anthony
    Rejtar, Tomas
    Li, Lingyun
    Karger, Barry L.
    Makarova, Kira
    Koonin, Eugene V.
    Lewis, Kim
    [J]. JOURNAL OF BACTERIOLOGY, 2006, 188 (24) : 8360 - 8367
  • [8] One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
    Datsenko, KA
    Wanner, BL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) : 6640 - 6645
  • [9] Joint tolerance to β-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA
    Falla, TJ
    Chopra, I
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) : 3282 - 3284
  • [10] Hobby GL, 1942, P SOC EXP BIOL MED, V50, P281, DOI 10.3181/00379727-50-13773